ArticleJournal for immunotherapy of cancer2019

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.

Nikolaus B Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.